Oh YK - Search Results

1

Effect of HPV E6/E7 siRNA with Chemotherapeutic Agents on the Regulation of TP53/E2F Dynamic Behavior for Cell Fate Decisions.

Rajasekaran N, Jung HS, Bae SH, Chelakkot C, Hong S, Choi JS, Yim DS, Oh YK, Choi YL, Shin YK. Rajasekaran N, et al. Among authors: oh yk. Neoplasia. 2017 Oct;19(10):735-749. doi: 10.1016/j.neo.2017.07.005. Epub 2017 Aug 24. Neoplasia. 2017. PMID: 28843398 Free PMC article.

2

The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo.

Jung HS, Erkin OC, Kwon MJ, Kim SH, Jung JI, Oh YK, Her SW, Ju W, Choi YL, Song SY, Kim JK, Kim YD, Shim GY, Shin YK. Jung HS, et al. Among authors: oh yk. Int J Cancer. 2012 Apr 15;130(8):1925-36. doi: 10.1002/ijc.26197. Epub 2011 Aug 8. Int J Cancer. 2012. PMID: 21630254

3

Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA.

Yu YH, Kim E, Park DE, Shim G, Lee S, Kim YB, Kim CW, Oh YK. Yu YH, et al. Among authors: oh yk. Eur J Pharm Biopharm. 2012 Feb;80(2):268-73. doi: 10.1016/j.ejpb.2011.11.002. Epub 2011 Nov 13. Eur J Pharm Biopharm. 2012. PMID: 22108492

4

Molecular engineering of antibodies for site-specific conjugation to lipid polydopamine hybrid nanoparticles.

Yang H, Le QV, Shim G, Oh YK, Shin YK. Yang H, et al. Among authors: oh yk. Acta Pharm Sin B. 2020 Nov;10(11):2212-2226. doi: 10.1016/j.apsb.2020.07.006. Epub 2020 Jul 18. Acta Pharm Sin B. 2020. PMID: 33304787 Free PMC article.

5

Novel cationic cholesterol derivative-based liposomes for serum-enhanced delivery of siRNA.

Han SE, Kang H, Shim GY, Suh MS, Kim SJ, Kim JS, Oh YK. Han SE, et al. Among authors: oh yk. Int J Pharm. 2008 Apr 2;353(1-2):260-9. doi: 10.1016/j.ijpharm.2007.11.026. Epub 2007 Nov 22. Int J Pharm. 2008. PMID: 18178348

6

Cationic derivatives of biocompatible hyaluronic acids for delivery of siRNA and antisense oligonucleotides.

Han SE, Kang H, Shim GY, Kim SJ, Choi HG, Kim J, Hahn SK, Oh YK. Han SE, et al. Among authors: oh yk. J Drug Target. 2009 Feb;17(2):123-32. doi: 10.1080/10611860802472461. J Drug Target. 2009. PMID: 19012052

7

siRNA conjugate delivery systems.

Jeong JH, Mok H, Oh YK, Park TG. Jeong JH, et al. Among authors: oh yk. Bioconjug Chem. 2009 Jan;20(1):5-14. doi: 10.1021/bc800278e. Bioconjug Chem. 2009. PMID: 19053311 Review.

8

siRNA delivery systems for cancer treatment.

Oh YK, Park TG. Oh YK, et al. Adv Drug Deliv Rev. 2009 Aug 10;61(10):850-62. doi: 10.1016/j.addr.2009.04.018. Epub 2009 May 5. Adv Drug Deliv Rev. 2009. PMID: 19422869 Review.

9

Tocopheryl oligochitosan-based self assembling oligomersomes for siRNA delivery.

Noh SM, Han SE, Shim G, Lee KE, Kim CW, Han SS, Choi Y, Kim YK, Kim WK, Oh YK. Noh SM, et al. Among authors: oh yk. Biomaterials. 2011 Jan;32(3):849-57. doi: 10.1016/j.biomaterials.2010.09.027. Biomaterials. 2011. PMID: 20926129

10

Trilysinoyl oleylamide-based cationic liposomes for systemic co-delivery of siRNA and an anticancer drug.

Shim G, Han SE, Yu YH, Lee S, Lee HY, Kim K, Kwon IC, Park TG, Kim YB, Choi YS, Kim CW, Oh YK. Shim G, et al. Among authors: oh yk. J Control Release. 2011 Oct 10;155(1):60-6. doi: 10.1016/j.jconrel.2010.10.017. Epub 2010 Nov 4. J Control Release. 2011. PMID: 20971142

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

690 results

Search Page

Filters